NICE Supports Routine NHS Funding and Access to Ex-Situ Machine Perfusion in a Major Step Forward for Liver Transplantation

Contributed by: GlobeNewswire

Tags

MedTech

More Like This

OrganOx Opens State-of-the-Art Research, Development, and Production Headquarters in Oxford, UK

OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector

OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation

OrganOx Announces Appointment of Naoya Iwata as CEO & President

OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting

OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital

PR Newswire associated0

First-Ever Comparative Study of Hypothermic Oxygenated Machine Perfusion (HOPE) with Normothermic Machine Perfusion (NMP) in Liver Transplantation Shows Better Outcomes With HOPE